| A CLOCK-binding small molecule disrupts the interaction between CLOCK and BMAL1 and enhances circadian rhythm amplitude YU Doruk, D Yarparvar, YK Akyel, S Gul, AC Taskin, F Yilmaz, I Baris, ... Journal of Biological Chemistry 295 (11), 3518-3531, 2020 | 56 | 2020 |
| Discovery of a small molecule that selectively destabilizes Cryptochrome 1 and enhances life span in p53 knockout mice S Gul, YK Akyel, ZM Gul, S Isin, O Ozcan, T Korkmaz, S Selvi, I Danis, ... Nature Communications 13 (1), 6742, 2022 | 20 | 2022 |
| Pharmacist’s role in pharmacotherapeutic management of Alzheimer’s disease NÇ Yılmaz, M Altuntaş, YK Akyel, BSU Doğan İstanbul Journal of Pharmacy 47 (1), 1-4, 2017 | 14 | 2017 |
| Circadian dysfunction in adipose tissue: chronotherapy in metabolic diseases E Civelek, D Ozturk Civelek, YK Akyel, D Kaleli Durman, A Okyar Biology 12 (8), 1077, 2023 | 10 | 2023 |
| Diurnal Changes in Capecitabine Clock-Controlled Metabolism Enzymes Are Responsible for Its Pharmacokinetics in Male Mice YK Akyel, D Ozturk Civelek, N Ozturk Seyhan, S Gul, I Gazioglu, ... Journal of Biological Rhythms, 07487304221148779, 2023 | 5 | 2023 |
| TW68, cryptochromes stabilizer, regulates fasting blood glucose levels in diabetic ob/ob and high fat-diet-induced obese mice S Surme, C Ergun, S Gul, YK Akyel, ZM Gul, O Ozcan, OS Ipek, BA Akarlar, ... Biochemical Pharmacology 218, 115896, 2023 | 1 | 2023 |
| TW68, Cryptochromes stabilizer, regulates fasting blood glucose level in ob/ob and fat-induced diabetic mice S Surme, C Ergun, S Gul, YK Akyel, ZM Gul, O Ozcan, OS Ipek, BA Akarlar, ... bioRxiv, 2023.07. 13.548861, 2023 | 1 | 2023 |
| The role of the circadian timing system on drug metabolism and detoxification: an update A Okyar, D Ozturk Civelek, YK Akyel, S Surme, Z Pala Kara, İH Kavakli Expert Opinion on Drug Metabolism & Toxicology, 2024 | | 2024 |
| Dosing‐time, feeding, and sex‐dependent variations of everolimus pharmacokinetics in mice D Ozturk Civelek, N Ozturk Seyhan, YK Akyel, I Gazioglu, Z Pala Kara, ... Fundamental & Clinical Pharmacology, 2024 | | 2024 |
| Dosing-time, feeding, and sex-dependent variations of everolimus pharmacokinetics in mice. DO Civelek, NO Seyhan, YK Akyel, I Gazioglu, ZP Kara, M Orman, ... Authorea Preprints, 2023 | | 2023 |
| Circadian Variations in the Pharmacokinetics of Capecitabine in Mice YK Akyel, D Ozturk Civelek, N Ozturk Seyhan, S Gul, I Gazioglu, ... BP-D-22-01317, 2022 | | 2022 |
| The association of ABCC5 and ABCC11 polymorphisms with the pharmacokinetics of 5-FU in advanced gastric cancer patients ZP Kara, E Oztas, D Ozturk, Y Akyel, Z Turna, A Okyar, G Özhan Clinical and Experimental Health Sciences 10 (3), 285-291, 2020 | | 2020 |
| SS-73: Everolimusun kronofarmakokinetiği: Uygulama zamanı, cinsiyet ve beslenme durumunun etkisi F Öztürk, D ÖZTÜRK, A Yasemin Kübra, Z PALA KARA, A OKYAR | | 2019 |
| PS-64: mTOR İnhibitörü Everolimusun Yaşa Bağlı Farmakokinetiği F Öztürk, A Yasemin Kübra, N ÖZTÜRK, Z PALA KARA, A OKYAR | | 2019 |
| PS-01: Zamana bağlı everolimus uygulamasının dişi ve erkek farelerde P-glikoprotein ekspresyonuna etkisi F Öztürk, A Yasemin Kübra, D ÖZTÜRK, N ÖZTÜRK, Z PALA KARA, ... | | 2019 |
| Circadian and sex-dependent pharmacokinetics of everolimus and implications of chronotherapy D Öztürk, I GAZİOĞLU, A OKYAR | | 2019 |
